Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duyiwei capsules vs diclofenac for cervical spondylotic radiculopathy
ChiCTR2400080418Phase 4Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Jan 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of duyiwei in cervical spondylotic radiculopathy (CSR) (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoints: Visual analogue pain score (VAS) and Neck Disability Index (NDI). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
duyiwei
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on ChiCTR2400080418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080418.